Morocco autism screening program commences in three cities
BlinkLab Limited (ASX:BB1) announced the commencement of its nationwide autism screening program for the Kingdom of Morocco in Tangier, Fes and Agadir. The cities mark the first operational launch phase of Morocco’s previously announced nationwide, government-funded autism screening initiative.
BlinkLab staff recently travelled to Tangier to train local healthcare professionals and support the initial implementation. According to the company, Morocco is moving from a policy framework into clinical practice, following the national framework announced on 23 March 2026.
The company describes the launch as providing the first live implementation reference point for the broader national program.
Key launch facts
- Cities: Tangier, Fes and Agadir
- Backing: High Instructions of His Majesty King Mohammed VI
- Scale: ~600,000 children born annually across a large geographical footprint
- Technology: smartphone-based autism screening
When big ASX news breaks, our subscribers know first
From national framework to real-world rollout
The announcement describes the launch as the first practical step in translating Morocco’s government-led initiative into a live operational program. The initial commencement in Tangier was described as a significant milestone, marking the transition from national program design to real-world implementation across a nationwide healthcare system.
The national framework
The program is being launched pursuant to the High Instructions of His Majesty King Mohammed VI. It sits within a formal national framework involving:
- Foundation Mohammed V for Solidarity
- Ministry of Higher Education, Scientific Research and Innovation
- Ministry of Health and Social Protection
- Ministry of Solidarity, Social Integration and the Family
The initiative is described as nationwide and government-funded. The announcement does not disclose any contract value or revenue.
Training and clinical integration
BlinkLab staff have been on site to support training for frontline personnel. This is intended to help prepare the first operational teams to use the company’s smartphone-based autism screening technology within the broader Moroccan clinical pathway.
Dr Henk-Jan Boele, Managing Director and CEO of BlinkLab
“We are proud to see the Morocco Autism Screening Program enter its first operational phase across three major cities, bringing our technology into clinical practice…”
The announcement says staff “recently travelled to Tangier”, while Dr Boele’s comments refer to a team visit to Morocco “in June”. The source does not give an exact training date.
How smartphone-based autism screening works
Autism screening aims to identify children who may benefit from further assessment. Early identification matters because it enables timely intervention during critical periods of brain development, according to the company.
BlinkLab’s most advanced product, BlinkLab Dx1, is an autism diagnostic aid for clinicians. It leverages smartphones, artificial intelligence and machine learning to capture objective, reflex-based measures, supporting earlier and more accurate autism identification.
The underlying approach has peer-reviewed validation from a 536-child multi-centre study, which found that a smartphone can objectively detect autism-related sensorimotor differences.
The announcement refers only to “smartphone-based autism screening technology” in the Moroccan program and does not state that Dx1 is the tool being deployed.
A smartphone-based approach may suit a nationwide system serving a large population. That remains the company’s positioning rather than a guaranteed outcome.
Strategic significance and regional outlook
BlinkLab states that the launch further strengthens its global clinical and public-health narrative. In its view, the commencement shows that its technology can be introduced within a government-led autism screening framework at the point of care.
The company also noted that after the rollout in Tangier, Fes and Agadir, success “may support phased expansion across Morocco” and strengthen the Kingdom’s role as a regional example for broader autism screening and neurodevelopmental programs.
Dr Mohamed Azami, Coordinator and Administrator of the Mohammed V Foundation for Solidarity
“…Morocco’s ambition is not simply to pilot a local initiative, but to establish a model of implementation that can be scaled across the Kingdom, integrated into public-health and specialist services, and strengthened over time through training, education and research. This program is also part of a broader national vision: to position Morocco as a regional leader in the use of innovative healthcare tools that can improve lives while expanding access…”
Dr Azami also said that “In time, the experience gained in Morocco may support broader collaboration across North Africa, the Gulf and the wider Middle East…” This is an aspiration rather than a commitment.
Investors exploring how the Morocco rollout fits alongside the company’s US regulatory work can read our full explainer on BlinkLab’s pivotal FDA study, which covers the 10-site design, the recruitment timeline and the targeted year-end 2026 submission.
Milestone summary
| Milestone | Status | Investor relevance |
|---|---|---|
| National framework announced (23 March 2026) | Completed | Government backing |
| Staff training | Under way | Operational readiness |
| Launch in three cities | Commenced | First live reference point |
| Wider Morocco expansion | Not confirmed | Potential upside |
What investors may watch
The announcement does not disclose revenue, pricing, screening volumes, expansion timelines or commercial terms. Items that may be worth monitoring in future announcements include:
- Any phased expansion across Morocco
- Screening volumes
- Any commercial terms
Want the Next Healthcare Breakout in Your Inbox?
Get FREE breaking ASX healthcare news delivered within minutes of release, with in-depth analysis already done. Join 20,000+ subscribers who stay ahead of the market with Big News Blast. Click the “Free Alerts” button to receive real-time alerts the moment market-moving announcements land.